Juventas Therapeutics Enrolls First Patient in Phase 2 Gene Therapy Clinical Trial for Treatment of Advanced Peripheral Artery Disease Genetics Investing
Human Longevity, Inc. Appoints Key Oncology Leader, Kenneth J. Bloom, M.D., to Head Oncology and Immunotherapy Program Genetics Investing
Merck Obtains Approval of ZEPATIER™ in Canada for the Treatment of Chronic Hepatitis C for Patients with Genotype 1, 3, or 4 Infection Following Priority Review Pharmaceutical Investing
TapImmune Granted Fast Track Designation by FDA for Lead Vaccine TPIV 200 in the Treatment of Ovarian Cancer Genetics Investing
GenomeFIRST Awarded $400K Grant to Bring Genomic Information into Patients' Care Plans Genetics Investing
Stanford Researchers Publish Seminal Paper on Use of 10x Genomics’ GemCode™ Technology for Genomic Analysis Genetics Investing
Amarantus Reports Issuance of Chinese Patent Covering Use of MANF for the Treatment of Parkinson's Disease Biotech Investing
Human Longevity Inc. Acquires Stem Cell Banking from Celgene Cellular Therapeutics Genetics Investing